Elixir Pharmaceuticals

Elixer Pharmaceuticals, no longer operating, was focused on the discovery, development, and commercialization of pharmaceuticals for treating metabolic diseases, such as diabetes and obesity.

Overview Structured Data Issues Contributors

Is a

Company

Organization

Company attributes

Industry

Location

Cambridge, Cambridgeshire

AngelList URL

angel.co/elixir-pha...maceuticals

CIK Number

1,175,7840

Place of Incorporation

Delaware

Investors

JAFCO Asia

‌

Taiwan Global BioFund

YFY Biotech Management Company

Omega Funds

Oxford Bioscience Partners

ARCH Venture Partners

MPM Capital

DUNS Number

0869564680

IRS Number

61,549,4310

Total Funding Amount (USD)

58,000,000

Latest Funding Round Date

May 27, 2009

Latest Funding Type

Series D

CAGE Code

5H1S10

Wellfound ID

elixir-pharmaceuticals

Other attributes

Company Operating Status

Closed

SIC Code

2,8340

Elixir Pharmaceuticals, no longer operating, was focused on the discovery, development, and commercialization of pharmaceuticals for treating metabolic diseases, such as diabetes and obesity.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Elixir Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.